Cysteine protease inhibitor e64 reduces the rate of formation of selenite cataract in the whole animal

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The purpose of this experiment was to test the effectiveness of E64 in prevention of selenite nuclear cataract in the whole animal. E64 is an inhibitor of cysteine proteases such as calpain (EC.3.4.22.17). In the whole animal, daily intraperitoneal injection of E64 was mildly effective in slowing the rate of formation of selenite nuclear cataract, although prevention was not permanent. Frequency of the nuclear cataract in selenite group at 5 days post selenite injection was significantly decreased from 40% to 17% in the selenite+E64 group, and the density of cataract in the Se+E64 group was reduced. However, crystallins and calpain were still degraded in the selenite+E64 group. E64 was more effective against selenite cataract when present continuously during lens culture, where it slowed the rate of formation of nuclear opacity. Amelioration of cataract occurred both in vitro and in vivo even though lens calcium concentrations were elevated. The results supported the idea that application of calpain inhibitor is beneficial hi prevention of rodent selenite cataracts.

Original languageEnglish (US)
Pages (from-to)657-666
Number of pages10
JournalCurrent Eye Research
Volume10
Issue number7
DOIs
StatePublished - 1991

Fingerprint

Selenious Acid
Cysteine Proteinase Inhibitors
Cataract
Calpain
Lenses
Crystallins
Intraperitoneal Injections
Rodentia
Calcium
Injections

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Cysteine protease inhibitor e64 reduces the rate of formation of selenite cataract in the whole animal. / Azuma, Mitsuyoshi; David, Larry; Shearer, Thomas (Tom).

In: Current Eye Research, Vol. 10, No. 7, 1991, p. 657-666.

Research output: Contribution to journalArticle

@article{8985a60a439148a6a84d0ff8f5838e3f,
title = "Cysteine protease inhibitor e64 reduces the rate of formation of selenite cataract in the whole animal",
abstract = "The purpose of this experiment was to test the effectiveness of E64 in prevention of selenite nuclear cataract in the whole animal. E64 is an inhibitor of cysteine proteases such as calpain (EC.3.4.22.17). In the whole animal, daily intraperitoneal injection of E64 was mildly effective in slowing the rate of formation of selenite nuclear cataract, although prevention was not permanent. Frequency of the nuclear cataract in selenite group at 5 days post selenite injection was significantly decreased from 40{\%} to 17{\%} in the selenite+E64 group, and the density of cataract in the Se+E64 group was reduced. However, crystallins and calpain were still degraded in the selenite+E64 group. E64 was more effective against selenite cataract when present continuously during lens culture, where it slowed the rate of formation of nuclear opacity. Amelioration of cataract occurred both in vitro and in vivo even though lens calcium concentrations were elevated. The results supported the idea that application of calpain inhibitor is beneficial hi prevention of rodent selenite cataracts.",
author = "Mitsuyoshi Azuma and Larry David and Shearer, {Thomas (Tom)}",
year = "1991",
doi = "10.3109/02713689109013857",
language = "English (US)",
volume = "10",
pages = "657--666",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Cysteine protease inhibitor e64 reduces the rate of formation of selenite cataract in the whole animal

AU - Azuma, Mitsuyoshi

AU - David, Larry

AU - Shearer, Thomas (Tom)

PY - 1991

Y1 - 1991

N2 - The purpose of this experiment was to test the effectiveness of E64 in prevention of selenite nuclear cataract in the whole animal. E64 is an inhibitor of cysteine proteases such as calpain (EC.3.4.22.17). In the whole animal, daily intraperitoneal injection of E64 was mildly effective in slowing the rate of formation of selenite nuclear cataract, although prevention was not permanent. Frequency of the nuclear cataract in selenite group at 5 days post selenite injection was significantly decreased from 40% to 17% in the selenite+E64 group, and the density of cataract in the Se+E64 group was reduced. However, crystallins and calpain were still degraded in the selenite+E64 group. E64 was more effective against selenite cataract when present continuously during lens culture, where it slowed the rate of formation of nuclear opacity. Amelioration of cataract occurred both in vitro and in vivo even though lens calcium concentrations were elevated. The results supported the idea that application of calpain inhibitor is beneficial hi prevention of rodent selenite cataracts.

AB - The purpose of this experiment was to test the effectiveness of E64 in prevention of selenite nuclear cataract in the whole animal. E64 is an inhibitor of cysteine proteases such as calpain (EC.3.4.22.17). In the whole animal, daily intraperitoneal injection of E64 was mildly effective in slowing the rate of formation of selenite nuclear cataract, although prevention was not permanent. Frequency of the nuclear cataract in selenite group at 5 days post selenite injection was significantly decreased from 40% to 17% in the selenite+E64 group, and the density of cataract in the Se+E64 group was reduced. However, crystallins and calpain were still degraded in the selenite+E64 group. E64 was more effective against selenite cataract when present continuously during lens culture, where it slowed the rate of formation of nuclear opacity. Amelioration of cataract occurred both in vitro and in vivo even though lens calcium concentrations were elevated. The results supported the idea that application of calpain inhibitor is beneficial hi prevention of rodent selenite cataracts.

UR - http://www.scopus.com/inward/record.url?scp=0025779333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025779333&partnerID=8YFLogxK

U2 - 10.3109/02713689109013857

DO - 10.3109/02713689109013857

M3 - Article

C2 - 1914502

AN - SCOPUS:0025779333

VL - 10

SP - 657

EP - 666

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 7

ER -